Post–Renal Transplant Cytomegalovirus Infection: Study of Risk Factors-Reference-Cited by-同舟云学术

Post–Renal Transplant Cytomegalovirus Infection: Study of Risk Factors

Published:2012-04 Issue:3 Volume:44 Page:706-709
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

Kute V.B.,Vanikar A.V.,Shah P.R.,Gumber M.R.,Patel H.V.,Godara S.M.,Munjappa B.C.,Sainaresh V.V.,Engineer D.P.,Jain S.H.,Modi P.R.,Shah V.R.,Trivedi V.B.,Trivedi H.L.

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference14 articles.

1. Cytomegalovirus in renal transplantation;Brennan;J Am Soc Nephrol,2001

2. Canadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report;Preiksaitis;Am J Transplant,2005

3. Human cytomegalovirus and kidney transplantation: a clinician's update;De Keyzer;Am J Kidney Dis,2011

4. Cytomegalovirus disease after kidney transplantation: clues to accurate diagnosis;Nemati;Transplant Proc,2007

5. Signs and symptoms of cytomegalovirus disease in kidney transplant recipients;Pour-Reza-Gholi;Transplant Proc,2005

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Burden of neutropenia and leukopenia among adult kidney transplant recipients: A systematic literature review of observational studies;Transplant Infectious Disease;2023-01-19

2. Prophylaxis of Cytomegalovirus Infection in Solid Organ Transplantation, Retrospective Evaluation;Transplant Research and Risk Management;2022-06

3. Expert group opinion for respiratory infections in solid organ transplant recipients in South Asia;Indian Journal of Transplantation;2022

4. Assessment of risk factors and outcome of early versus late cytomegalovirus infection infection in living-related D+/R + renal allograft recipients;Indian Journal of Nephrology;2022

5. Cytomegalovirus in renal transplant recipients from living donors with and without valganciclovir prophylaxis and with immunosuppression based on anti-thymocyte globulin or basiliximab;International Journal of Infectious Diseases;2021-06